SEC 13F Intelligence

Bml Capital Management, LLC / MIST

Bml Capital Management, LLC’s Milestone Pharmaceuticals In Position

Does Bml Capital Management, LLC own Milestone Pharmaceuticals In (MIST)? Not currently — the last reported position was 1.14M shares worth $2M in Q2 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$2M
Q2 2025
Shares
1.14M
% of Portfolio
+1.67%
Quarters Held
11
position exited

Position History MIST

Reported value by quarter
Q4 ’22: $712,800Q4 ’22Q1 ’23: $866,800Q2 ’23: $776,625Q2 ’23Q3 ’23: $844,750Q4 ’23: $738,728Q4 ’23Q1 ’24: $1MQ2 ’24: $1MQ2 ’24Q3 ’24: $2MQ4 ’24: $3MQ4 ’24Q1 ’25: $908,986Q2 ’25: $2MQ2 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q2 20251.14M$2M+1.67%
Q1 20251.14M$908,986+0.74%
Q4 20241.14M$3M+1.67%
Q3 20241.14M$2M+1.02%
Q2 20241.10M$1M+1.04%
Q1 2024606.1K$1M+0.72%
Q4 2023442.4K$738,728+0.56%
Q3 2023272.5K$844,750+0.78%
Q2 2023272.5K$776,625+0.70%
Q1 2023220.0K$866,800+0.75%
Q4 2022180.0K$712,800+0.68%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Bml Capital Management, LLC’s full portfolio or all institutional holders of MIST.